Matches in Wikidata for { <http://www.wikidata.org/entity/Q97900939> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q97900939 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q97900939 description "scientific article published on 24 July 2020" @default.
- Q97900939 description "wetenschappelijk artikel" @default.
- Q97900939 description "наукова стаття, опублікована 24 липня 2020" @default.
- Q97900939 name "Denosumab Versus Zoledronic Acid in the Prevention of Skeletal-Related Events in Vulnerable Cancer Patients: A Meta-Analysis of Randomized, Controlled Trials" @default.
- Q97900939 name "Denosumab Versus Zoledronic Acid in the Prevention of Skeletal-Related Events in Vulnerable Cancer Patients: A Meta-Analysis of Randomized, Controlled Trials" @default.
- Q97900939 type Item @default.
- Q97900939 label "Denosumab Versus Zoledronic Acid in the Prevention of Skeletal-Related Events in Vulnerable Cancer Patients: A Meta-Analysis of Randomized, Controlled Trials" @default.
- Q97900939 label "Denosumab Versus Zoledronic Acid in the Prevention of Skeletal-Related Events in Vulnerable Cancer Patients: A Meta-Analysis of Randomized, Controlled Trials" @default.
- Q97900939 prefLabel "Denosumab Versus Zoledronic Acid in the Prevention of Skeletal-Related Events in Vulnerable Cancer Patients: A Meta-Analysis of Randomized, Controlled Trials" @default.
- Q97900939 prefLabel "Denosumab Versus Zoledronic Acid in the Prevention of Skeletal-Related Events in Vulnerable Cancer Patients: A Meta-Analysis of Randomized, Controlled Trials" @default.
- Q97900939 P1433 Q97900939-2EC57188-5A5F-46F3-B49D-99FAB5D633AE @default.
- Q97900939 P1476 Q97900939-D8B335A3-06A6-4908-BCB0-7F934957C97B @default.
- Q97900939 P2093 Q97900939-391A9A7E-277A-41B8-8EA9-A20823CA06BA @default.
- Q97900939 P2093 Q97900939-4D2ADEDA-7D0B-4FC7-A534-52DA3B5E404A @default.
- Q97900939 P2093 Q97900939-9BBB7560-DB15-431B-8408-C4EB0EB4A07B @default.
- Q97900939 P2093 Q97900939-A5E336AF-B3BE-4641-99BD-43331CFC1429 @default.
- Q97900939 P2093 Q97900939-BAE02992-2F37-4CC6-A484-CA8578463075 @default.
- Q97900939 P2093 Q97900939-BBFC4E4E-AAB5-4569-981D-BBC1AAD51A6E @default.
- Q97900939 P2093 Q97900939-C9F058D7-9D4B-4A69-A24D-50215F12109C @default.
- Q97900939 P2093 Q97900939-EE10FDA4-27FA-472F-927E-14E3D6AC0E21 @default.
- Q97900939 P31 Q97900939-D84AF280-149B-4240-82EA-EC58DB2760C4 @default.
- Q97900939 P356 Q97900939-958C3949-4AD7-4F3C-B900-9240294EDB4F @default.
- Q97900939 P577 Q97900939-46DE2C3D-77CE-45CD-ACA4-3A3B46DF62A6 @default.
- Q97900939 P698 Q97900939-C0D8BF20-CFFE-4A21-85A1-CD055575B953 @default.
- Q97900939 P921 Q97900939-2E03F7EF-B2D3-4177-B626-9573383DDE14 @default.
- Q97900939 P356 J.CLINTHERA.2020.05.019 @default.
- Q97900939 P698 32718784 @default.
- Q97900939 P1433 Q15716601 @default.
- Q97900939 P1476 "Denosumab Versus Zoledronic Acid in the Prevention of Skeletal-Related Events in Vulnerable Cancer Patients: A Meta-Analysis of Randomized, Controlled Trials" @default.
- Q97900939 P2093 "Chaoyang Chen" @default.
- Q97900939 P2093 "Lingyun Ma" @default.
- Q97900939 P2093 "Min Li" @default.
- Q97900939 P2093 "Ruoming Li" @default.
- Q97900939 P2093 "Shuang Zhou" @default.
- Q97900939 P2093 "Ting Yang" @default.
- Q97900939 P2093 "Yimin Cui" @default.
- Q97900939 P2093 "Ying Zhou" @default.
- Q97900939 P31 Q13442814 @default.
- Q97900939 P356 "10.1016/J.CLINTHERA.2020.05.019" @default.
- Q97900939 P577 "2020-07-24T00:00:00Z" @default.
- Q97900939 P698 "32718784" @default.
- Q97900939 P921 Q218507 @default.